Pricing Log in Create free account

Nuvilex Inc. (PMCB) vs Propanc Biopharma Inc (PPCB)

Nuvilex Inc. and Propanc Biopharma Inc are both Biotechnology companies. Nuvilex Inc. and Propanc Biopharma Inc are of similar size ($3.8M and $3.5M). Across the 10 metrics below, Nuvilex Inc. leads on 7 and Propanc Biopharma Inc on 3.

Valuation

Metric PMCB PPCB Biotechnology median
P/E n/m n/m 8.50
P/S n/m n/m 9.71
P/B 0.13 0.04 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA 3.82 n/m 0.64
EV/Sales n/m n/m 9.21
Earnings yield (679.41%) (5,398.12%) (33.15%)
Free cash flow yield (290.03%) (1,488.65%) (25.50%)

Profitability

Metric PMCB PPCB Biotechnology median
Gross margin 95.64% — 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (58.04%) (169.85%) (56.36%)
Return on assets (50.43%) (122.15%) (48.04%)
Return on invested capital 0.00% (125.86%) 0.00%

Growth

Metric PMCB PPCB Biotechnology median
Revenue growth (TTM) (71.06%) — 6.02%
EPS growth (last fiscal year) (186.83%) 95.25% 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric PMCB PPCB Biotechnology median
Debt to equity 0.00 0.05 0.00
Current ratio 40.29 2.55 4.72
Net debt to EBITDA 5.41 0.02 0.96

Dividend

Metric PMCB PPCB Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric PMCB PPCB Biotechnology median
Market cap 3.84m 3.53m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack